Viewing Study NCT05485350


Ignite Creation Date: 2025-12-24 @ 4:52 PM
Ignite Modification Date: 2025-12-28 @ 12:32 AM
Study NCT ID: NCT05485350
Status: UNKNOWN
Last Update Posted: 2022-08-03
First Post: 2022-07-09
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: Anlotinib , Penpulimab Combined With SBRT for Metastatic Non-Small Cell Lung Cancer (NSCLC)
Sponsor: Peking University Third Hospital
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module